Comparing outcomes of donation after cardiac death versus donation after brain death in liver transplant recipients with hepatitis C: A systematic review and meta-analysis

Canadian Journal of Gastroenterology and Hepatology

Volumn 28, Issue 2, 2014, Pages 103-108

  Wells, Malcolm ^a   Croome, Kris ^a   Janik, Toni ^b   Hernandez Alejandro, Roberto ^a   Chandok, Natasha ^a  

^a WESTERN UNIVERSITY   (Canada)

^b Hotel Dieu Grace Hospital Windsor   (Canada)

Author keywords

Biliary complications; Donation after cardiac death; Hepatitis C; Liver transplantation; Outcomes

Indexed keywords

BRAIN DEATH; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HEPATITIS C; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; META ANALYSIS; ORGAN DONOR; PRIORITY JOURNAL; RETRANSPLANTATION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BRAIN DEATH; DEATH; GRAFT SURVIVAL; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; RECURRENCE; REOPERATION; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84904267751     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2014/421451     Document Type: Review

References (30)

1. de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: Long-term follow-up from a single center. Am J Transpl 2009;9:773-81.
2. Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single-center experience. Liver Transpl 2009;15:1028-35.
3. Fujita S, Mizuno S, Fujikawa T, et al. Liver transplantation from donation after cardiac death: A single center experience. Transplantation 2007;84:46-9. (Pubitemid 47094640)
4. Pine JK, Aldouri A, Young AL, et al. Liver transplantation following donation after cardiac death: An analysis using matched pairs. Liver Transpl 2009;15:1072-82.
5. Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death: The University of Wisconsin experience with liver transplantation. Ann Surg 2005;242:724-31. (Pubitemid 41567129)
6. Chan EY, Olson LC, Kisthard JA, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2008;14:604-10. (Pubitemid 351696270)
7. Watt K, Veldt B, Charlton M. A practical guide to the management of HCV infection following liver transplantation. Am J Transpl 2009;9:1707-13.
8. Uemura T, Ramprasad V, Hollenbeak CS, Bezinover D, Kadry Z. Liver transplantation for hepatitis C from donation after cardiac death donors: An analysis of OPTN/UNOS data. Am J Transpl 2012;12:984-91.
9. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. (Pubitemid 34267271)
10. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-78. (Pubitemid 33078280)
11. Harring TR, Nguyen NT, Cotton RT, et al. Liver transplantation with donation after cardiac death donors: A comprehensive update. J Surg Res 2012;178:502-11.
12. Neumann UP, Berg T, Bahra M, et al. Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up. Transplantation 2004;77:226-31. (Pubitemid 38155751)
13. Hernadez-Alejandro R, Wall W, Jevnikar A, et al. Organ donation after cardiac death: Donor and recipient outcomes after the first three years of the Ontario experience. Can J Anaesthes 2011;58:599-605.
14. Furukawa H, Taniguchi M, Fujiyoshi M, Oota M. Experience using extended criteria donors in first 100 cases of deceased donor liver transplantation in Japan. Transpl Proc 2012;44:373-5.
15. Cameron A, Busuttil RW. AASLD/ILTS transplant course: Is there an extended donor suitable for everyone? Liver Transpl 2005(11 Suppl 2):S2-5. (Pubitemid 43072606)
16. Baccarani U, Adani GL, Toniutto P, et al. Liver transplantation from old donors into HCV and non-HCV recipients. Transpl Proc 2004;36:527-8.
17. Tao R, Ruppert K, Cruz RJ Jr, et al. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts. Liver Transpl 2010;16:1288-95.
18. Taner CB, Bulatao IG, Keaveny AP, et al. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl 2011;17:641-9.
19. Hernandez-Alejandro R, Croome KP, Quan D, et al. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts. Transplantation 2011;92:686-9.
20. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. (Pubitemid 351632017)
21. Allam N, Al Saghier M, El Sheikh Y, et al. Clinical outcomes for Saudi and Egyptian patients receiving deceased donor liver transplantation in China. Am J Transpl 2010;10:1834-41.
22. Chen T, Jia H, Li J, Chen X, Zhou H, Tian H. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: Meta-analysis of clinical studies. Transpl Int 2009;22:408-15.
23. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transpl 2006;6:783-90. (Pubitemid 43345017)
24. Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single-center experience. Liver Transpl 2009;15:1028-35.
25. Hong JC, Yersiz H, Kositamongkol P, et al. Liver transplantation using organ donation after cardiac death: A clinical predictive index for graft failure-free survival. Arch Surg 2011;146:1017-23.
26. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: Predictors of outcome. Am J Transpl 2010;10:2512-9.
27. Ortiz J, Feyssa EL, Parsikia A, et al. Severe hepatitis C virus recurrence is nearly universal after donation after cardiac death liver transplant. Exp Clin Transpl 2011;9:105-12.
28. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study. Am J Transpl 2010;10:1420-7.
29. Xirouchakis E, Triantos C, Manousou P, et al. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: Systematic review and meta-analysis of prospective controlled studies. J Viral Hepat 2008;15:699-709.
30. Garcia-Valdecasas JC. DCD donors: A unique source to significantly increase organ donation. J Hepatol 2011;55:745-6.